B9688

Pizotifen

≥98% (HPLC)

• Sinonimo/i: Pizotifen, Pizotyline; 4-(9,10-Dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thien-4-ylidene)-1-methylpiperidine
• Formula empirica (notazione di Hill): C₁₉H₂₁NS
• Numero CAS: 15574-96-6
• Peso molecolare: 295.44
• NACRES: NA.77
• PubChem Substance ID: 329773323
• UNSPSC Code: 12352200
• EC Number: 239-632-9
• MDL number: MFCD00864192
• Assay: ≥98% (HPLC)
• Form: powder

Proprietà

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• solubility: DMSO: ≥8 mg/mL
• originator: Novartis
• storage temp.: room temp
• SMILES string: CN1CCC(\CC1)=C2\c3ccccc3CCc4sccc24
• InChI: 1S/C19H21NS/c1-20-11-8-15(9-12-20)19-16-5-3-2-4-14(16)6-7-18-17(19)10-13-21-18/h2-5,10,13H,6-9,11-12H2,1H3
• InChI key: FIADGNVRKBPQEU-UHFFFAOYSA-N

Descrizione

Biochem/physiol Actions

Pizotifen is a Serotonin antagonist used for prophylaxis of migraine

Pizotifen is a serotonin antagonist acting mainly at the 5-HT1, 5-HT2A and 5HT2C receptors with some antihistamine activity. It is used for the prevention of vascular headache including migraine and cluster headache.

Features and Benefits

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Informazioni sulla sicurezza

• pictograms: GHS08,GHS07
• signalword: Warning
• hcodes: H302,H361
• pcodes: P202 - P264 - P280 - P301 + P312 - P308 + P313 - P405
• Hazard Classifications: Acute Tox. 4 Oral - Repr. 2
• Classe di stoccaggio: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable